Aronson, Jeffrey: transcript of a video interview (25-Apr-2016)
View/ Open
Series
History of Modern Biomedicine Interviews (Digital Collection);e2016055
History of Modern Biomedicine Interviews (Digital Collection);e2016056
History of Modern Biomedicine Interviews (Digital Collection);e2016057
History of Modern Biomedicine Interviews (Digital Collection);e2016058
History of Modern Biomedicine Interviews (Digital Collection);e2016059
History of Modern Biomedicine Interviews (Digital Collection);e2016060
History of Modern Biomedicine Interviews (Digital Collection);e2016061
History of Modern Biomedicine Interviews (Digital Collection);e2016062
History of Modern Biomedicine Interviews (Digital Collection);e2016063
History of Modern Biomedicine Interviews (Digital Collection);e2016064
History of Modern Biomedicine Interviews (Digital Collection);e2016065
History of Modern Biomedicine Interviews (Digital Collection);e2016066
History of Modern Biomedicine Interviews (Digital Collection);e2016067
DOI
10.17636/01014790
Metadata
Show full item recordAbstract
Interview with Dr Jeffrey Aronson, conducted by Professor Tilli Tansey, for the History of Modern Biomedicine Research Group, 25 April 2016, in the School of History, Queen Mary University of London. Transcribed by Mrs Debra Gee, and edited by Professor Tilli Tansey and Dr Apostolos Zarros. The project management and the technical support (filming and production) were undertaken by Mr Adam Wilkinson and Mr Alan Yabsley, respectively. Dr Jeffrey Aronson DPhil FRCP HonFBPhS HonFFPM (b. 1947) trained in the University of Glasgow (1964-1973) and the Medical Research Council (MRC) Unit and University Department of Clinical Pharmacology, Oxford, under the late Professor David Grahame-Smith. He was Reader in Clinical Pharmacology at the University of Oxford, and Honorary Consultant Physician in the Oxford University Hospitals Trust until 2014, since when he has held honorary contracts as a Consultant Physician and Clinical Pharmacologist in Oxford. He was President of the British Pharmacological Society (2008-2009) and is now Emeritus President. He was Vice-Chairman of the Medicines Commission (2002-2005) and Editor-in-Chief of the 'British Journal of Clinical Pharmacology' (2003-2007). He has been Chairman of the British Pharmacopoeia Commission’s Expert Advisory Group on Nomenclature since 2006. He was a Member of the Formulary Committees of the 'British National Formulary' from 2006 and the 'British National Formulary for Children' from 2003, and is now a Member of the Advisory Board of the 'British National Formulary'.
Authors
Tansey EM
Aronson J
Tansey EM
Zarros A
Gee D
Yabsley A
Wilkinson A